Related Experiment Video
Updated: Jun 26, 2026
06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Fragment-based QSAR: perspectives in drug design.
Lívia B Salum1, Adriano D Andricopulo
1Laboratório de Química Medicinal e Computacional, Centro de Biotecnologia Molecular Estrutural, Instituto de Física de São Carlos, Universidade de São Paulo, 13560-970 São Carlos, SP, Brazil.
Molecular Diversity
|February 3, 2009
Summary
Hologram Quantitative Structure-Activity Relationship (HQSAR) is a 2D fragment-based method that has evolved for drug design. It is a versatile tool for virtual screening and predicting pharmacokinetic properties.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
Background:
- Drug design integrates experimental and computational methods for innovation.
- Medicinal chemistry offers various approaches for hit identification, lead generation, and optimization.
- Quantitative Structure-Activity Relationship (QSAR) is crucial for designing small molecules with clinical utility.
Purpose of the Study:
- To provide a perspective on the evolution and current status of Hologram QSAR (HQSAR).
- To highlight the challenges and opportunities of HQSAR in modern drug design.
Main Methods:
- Hologram QSAR (HQSAR) is a 2D fragment-based QSAR method utilizing specialized molecular fingerprints.
- HQSAR is applicable to both large and traditional data sets, demonstrating its versatility.
- The approach has advanced from classical QSAR modeling to virtual screening and pharmacokinetic property prediction.
Main Results:
- HQSAR has evolved into an advanced tool for drug design.
- The method is effective for data correlation, prediction, virtual screening, and pharmacokinetic property prediction.
- HQSAR serves as a versatile tool applicable to various data set sizes.
Conclusions:
- HQSAR is a significant and evolving method in drug design.
- The technique offers advanced capabilities beyond traditional QSAR modeling.
- Future opportunities lie in addressing current challenges to further enhance HQSAR's utility in drug discovery.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...